Cytosorbents Corporation CTSO
4.62 USD +0.86 (+22.87%)
Nov 3, 2026, 3:45 PM EST
4.11 Day range 4.67
2.84 52-week range 17.00
- YTD
- -63.85%
- 1 year
- -70.42%
Analyst view
Consensus: buy
Buy
Price target (mean) 5.00 +8.2% upside
Now 4.62
- Target (low)
- 1.00
- Target (mean)
- 5.00
- Target (high)
- 10.00
Ratings (0m) 2 1 buy · 1 hold · 0 sell
- Strong buy0
- Buy1
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
- 2 months ago 2
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.07 | -0.07 – -0.07 | -0.12 | +41.7% | 9.45M | +9.1% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 10.09M | +3.1% | 0 |
| Current year | -0.30 | -0.30 – -0.30 | -0.64 | +53.1% | 38.53M | +6.0% | 1 |
| Next year | -0.14 | -0.14 – -0.14 | -0.30 | +53.3% | 43.45M | +12.8% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 12, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Nov 11, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Nov 8, 2024 | EF Hutton | Maintained | Buy | Buy |
| Nov 4, 2024 | EF Hutton | Maintained | Buy | Buy |
| Oct 22, 2024 | EF Hutton | Maintained | Buy | Buy |
| Oct 1, 2024 | EF Hutton | Maintained | Buy | Buy |
| Aug 14, 2024 | EF Hutton | Maintained | Buy | Buy |
| Aug 14, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Jul 29, 2024 | EF Hutton | Initiated | — | Buy |
| May 15, 2024 | B. Riley Securities | Reiterated | Buy | Buy |
| May 7, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Mar 15, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Dec 29, 2023 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Aug 2, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 3, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 10, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Nov 4, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 4, 2022 | B. Riley Securities | Maintained | — | Buy |
| May 4, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Sep 17, 2020 | Jefferies | Initiated | — | Buy |
| Sep 1, 2020 | SVB Leerink | Initiated | — | Outperform |
| May 6, 2020 | B. Riley Securities | Maintained | — | Buy |
| May 6, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 8, 2017 | Maxim Group | Maintained | — | Buy |
| Jun 7, 2017 | Cowen & Co. | Initiated | — | Outperform |
| Oct 26, 2016 | Aegis Capital | Initiated | — | Buy |
| Oct 7, 2016 | B. Riley Securities | Initiated | — | Buy |
| Mar 5, 2015 | MLV & Co. | Initiated | — | Buy |
| Feb 25, 2015 | WBB Securities | Initiated | — | Speculative Buy |